Cargando…
Adjuvant high dose rate brachytherapy for soft tissue sarcomas: initial experience report
PURPOSE: Adjuvant high-dose-rate brachytherapy (HDRBT) offers advantages over low dose rate brachytherapy (LDRBT), although there are little data on local tumor control and treatment related toxicity. We report outcome in patients with primary, recurrent, and metastatic extremity and superficial tru...
Autores principales: | Bradley, Julie A., Kleinman, Sara H., Rownd, Jason, King, David, Hackbarth, Donald, Whitfield, Robert, Wang, Dian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108830/ https://www.ncbi.nlm.nih.gov/pubmed/27877194 http://dx.doi.org/10.5114/jcb.2011.21036 |
Ejemplares similares
-
Low Dose-Rate Interstitial Brachytherapy in Soft Tissue Sarcomas
por: Rosenblatt, Edward, et al.
Publicado: (1999) -
Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas
por: Cortesi, Annalisa, et al.
Publicado: (2017) -
Midterm Results of High-Dose-Rate Intraoperative Brachytherapy in the Treatment of Soft Tissue Sarcomas
por: Dammerer, Dietmar, et al.
Publicado: (2023) -
Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy
por: Bedi, Meena, et al.
Publicado: (2013) -
Evidence and clinical outcomes of adult soft tissue sarcomas of the extremities treated with adjuvant high-dose-rate brachytherapy – a literature review
por: Pellizzon, Antonio Cássio Assis
Publicado: (2014)